Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Jing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6438-9113; OpenAlex author ID A5016471689, A5090361577. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 5

  1. Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study. Co-author DOI 10.1002/cai2.123↗
  2. Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. First author DOI 10.1016/j.tice.2022.101867↗
  3. SQLE facilitates the pancreatic cancer progression via the lncRNA-TTN-AS1/miR-133b/SQLE axis. Co-author DOI 10.1111/jcmm.17347↗
  4. Suppressing LncRNA HOXA-AS3 by CRISPR-dCas9 inhibits pancreatic cancer development. Last author DOI 10.7150/jca.62631↗
  5. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis. Co-author DOI 10.3892/mmr.2018.9663↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Boyu Qin · 1 shared paper, 2024 · strength 0.19
  2. Bo Yeun Yang · 1 shared paper, 2024 · strength 0.19
  3. Ke Li · 1 shared paper, 2024 · strength 0.19
  4. Xiaoli Zhang · 1 shared paper, 2021 · strength 0.17
  5. Lei Dong · 1 shared paper, 2022 · strength 0.15
  6. Hong Li · 1 shared paper, 2022 · strength 0.15
  7. Shuhui Wang · 1 shared paper, 2022 · strength 0.15
  8. Ting Wang · 1 shared paper, 2022 · strength 0.15
  9. Huijie Gao · 1 shared paper, 2022 · strength 0.13
  10. Litao Zhang · 1 shared paper, 2022 · strength 0.13
  11. Yuntao Zhang · 1 shared paper, 2022 · strength 0.13
  12. Qiang Ren · 1 shared paper, 2022 · strength 0.13
  13. Sen Qiao · 1 shared paper, 2022 · strength 0.13
  14. Wei Qin · 1 shared paper, 2022 · strength 0.13
  15. Lingxin Meng · 1 shared paper, 2022 · strength 0.13
  16. Lukuan You · 1 shared paper, 2019 · strength 0.11
  17. Haitao Tao · 1 shared paper, 2019 · strength 0.11
  18. Yi Hu · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.